Our Pricing

Can NHS Prescribe Mounjaro? UK Availability Explained

Published: 11 September 2026

Can NHS prescribe Mounjaro is one of the most common questions we receive from patients seeking tirzepatide treatment for weight management. While Mounjaro (tirzepatide) is licensed in the UK for type 2 diabetes and weight loss, NHS availability remains extremely limited due to NICE guidance restrictions and supply constraints. Understanding your eligibility and exploring private prescription alternatives can help you access this effective treatment without lengthy delays.

Can NHS Prescribe Mounjaro: Current UK Availability

The short answer to can NHS prescribe Mounjaro is yes, but with significant restrictions. The MHRA licensed Mounjaro (tirzepatide) for weight management in November 2023, but NICE guidance limits NHS prescribing to specialist weight management services only [1]. Most GP surgeries cannot prescribe Mounjaro directly, meaning patients must be referred to hospital-based tier 3 or tier 4 weight management clinics.

Current NHS waiting lists for specialist weight management services range from 12 to 24 months in many regions, with some areas not accepting new referrals at all due to capacity constraints [2]. Even after referral, strict eligibility criteria apply: patients typically need a BMI of 35 or above (or 32.5 for certain ethnic groups) plus at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea. These restrictions mean the vast majority of patients seeking Mounjaro cannot access it through NHS channels within a reasonable timeframe.

NHS Mounjaro Eligibility Criteria: Who Can Get It?

Understanding whether you meet the criteria for can NHS prescribe Mounjaro depends on multiple clinical and administrative factors. NICE guidance NG253 specifies that tirzepatide should only be initiated by specialist multidisciplinary teams within tier 3 or tier 4 weight management services [3]. Patients must have completed intensive lifestyle interventions including dietary counselling, physical activity programmes, and behavioural support before pharmacological treatment is considered.

The clinical thresholds are strict: a BMI of 35 kg/m² or higher for most patients, or 32.5 kg/m² for individuals of South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean family background. Additionally, patients must demonstrate commitment to ongoing lifestyle modification and attend regular monitoring appointments. Those with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease are excluded from treatment [4].

Why NHS Capacity Limits Mounjaro Access

Even when patients meet eligibility criteria, NHS capacity constraints severely limit access. Specialist weight management services operate with fixed budgets and staffing levels that cannot accommodate the surge in demand for GLP-1 receptor agonists. Many NHS trusts have implemented internal rationing systems, prioritising patients with the highest clinical need or those with type 2 diabetes over weight management alone. This means answering can NHS prescribe Mounjaro often comes down to local commissioning decisions rather than national policy.

Can NHS Prescribe Mounjaro for Type 2 Diabetes?

Mounjaro's original indication was type 2 diabetes management, and this remains the primary route through which some NHS patients access tirzepatide. NICE technology appraisal TA924 recommends Mounjaro as a treatment option for adults with type 2 diabetes when metformin is contraindicated or not tolerated, or when dual therapy with metformin plus another drug has not achieved adequate glycaemic control [1].

However, even for diabetes management, can NHS prescribe Mounjaro depends on local formulary decisions and prescriber familiarity. Many NHS diabetes services still favour established GLP-1 receptor agonists like semaglutide (Ozempic) due to longer clinical experience and lower acquisition costs. Patients seeking Mounjaro specifically for diabetes may need to demonstrate inadequate response to other treatments or specific clinical circumstances that justify tirzepatide's use. The SURPASS clinical trial programme showed tirzepatide achieved superior HbA1c reductions compared to semaglutide, with SURPASS-2 demonstrating mean reductions of 2.46% with the 15mg dose versus 1.86% with semaglutide 1mg [5].

Private Prescription: Can NHS Prescribe Mounjaro Alternatives

For patients who cannot access Mounjaro through NHS channels, private prescription offers a faster and more accessible alternative. At Cured Pharmacy, Mounjaro is available from £124.99 following a clinical assessment by UK-registered prescribers, with £20 off your first order using code Weightlossnew. Our online consultation takes under 3 minutes, and approved prescriptions are dispensed from our GPhC-registered pharmacy (9012511) with next-day delivery across the UK.

When considering can NHS prescribe Mounjaro versus private options, patients should weigh the clinical urgency of treatment against NHS waiting times. Private prescription provides immediate access to the same licensed medication, dispensed to identical safety standards, with ongoing prescriber support and flexible dose titration. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription meets regulatory requirements and patient safety standards.

How Private Prescription Works at Cured Pharmacy

Our streamlined process makes accessing Mounjaro straightforward even when can NHS prescribe Mounjaro isn't a viable option. Complete our confidential online medical questionnaire covering your weight history, previous treatments, medical conditions, and current medications. A UK-registered independent prescriber reviews your assessment within 24 hours, and if clinically appropriate, issues a private prescription. Mounjaro is then dispensed from our pharmacy and delivered in discreet packaging directly to your address. Follow-up consultations and dose adjustments are included at no additional cost, ensuring continuity of care throughout your treatment journey.

Can NHS Prescribe Mounjaro: Cost Comparison

While NHS prescriptions carry a standard charge of £124.99 per item in England (free in Scotland, Wales, and Northern Ireland for most patients), the reality of can NHS prescribe Mounjaro means most patients never reach the point of paying this fee. The extended waiting times, specialist referral requirements, and strict eligibility criteria create barriers that make private prescription the only practical option for many individuals seeking timely treatment.

Private prescription costs reflect the full medication price plus clinical service fees. At Cured Pharmacy, transparent upfront pricing means you know the total cost before completing your consultation, with no hidden fees or subscription traps. Our pricing structure includes prescriber assessment, ongoing monitoring, dose adjustment consultations, and pharmacy dispensing fees. The £124.99 starting price (after £20 discount with code Weightlossnew) represents complete treatment access without the 12-24 month NHS waiting period [2].

Can NHS Prescribe Mounjaro: Making Your Decision

Deciding between NHS and private routes requires honest assessment of your clinical situation and timeline. If you meet strict NHS eligibility criteria and can wait 12-24 months for specialist assessment, pursuing NHS referral through your GP remains a valid option. However, if you need treatment sooner, don't meet the elevated BMI thresholds, or live in an area with suspended weight management referrals, private prescription provides immediate access to the same licensed medication with equivalent safety oversight.

When evaluating can NHS prescribe Mounjaro for your circumstances, consider that delayed treatment means prolonged exposure to obesity-related health risks including cardiovascular disease, type 2 diabetes progression, and metabolic complications. Clinical trials demonstrate that earlier intervention with tirzepatide produces better long-term outcomes, with the SURMOUNT-1 trial showing average weight reductions of 20.9% over 72 weeks with the 15mg maintenance dose [6]. At Cured Pharmacy, our clinical team can assess your eligibility and provide evidence-based guidance on whether Mounjaro represents an appropriate treatment option for your weight management goals.

Next Steps for Accessing Mounjaro Treatment

Whether you're exploring can NHS prescribe Mounjaro or ready to pursue private prescription, taking action starts with clinical assessment. For NHS routes, book an appointment with your GP to discuss referral to specialist weight management services, ensuring you understand local waiting times and eligibility criteria. For private prescription through Cured Pharmacy, start your online consultation today and receive a prescriber decision within 24 hours. Both pathways require commitment to lifestyle modification including dietary changes and increased physical activity to maximise treatment effectiveness and maintain long-term weight management success.

Scientific References

1. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating type 2 diabetes [TA924]. NICE. [accessed 11 September 2026]
2. Royal College of Physicians. (2024). Weight management services in England: Capacity and demand analysis. RCP Publications. [accessed 11 September 2026]
3. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management [NG253]. NICE. [accessed 11 September 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 11 September 2026]
5. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): a randomised, open-label, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 11 September 2026]
6. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 11 September 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 11 September 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 11 September 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 11 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.